Augmented interferon I signaling in a patient with COVID toes
J Dermatol
.
2021 May;48(5):e242-e243.
doi: 10.1111/1346-8138.15864.
Epub 2021 Mar 21.
Authors
Kazuhiro Komura
1
,
Yuki Ichimura
2
,
Naoko Okiyama
2
,
Kazuyoshi Watanabe
3
,
Hiroaki Muramoto
3
,
Takashi Matsushita
4
Affiliations
1
Department of Dermatology, Japan Community Health Care Organization Kanazawa Hospital, Kanazawa, Japan.
2
Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
3
Department of Internal Medicine, Japan Community Health Care Organization Kanazawa Hospital, Kanazawa, Japan.
4
Department of Dermatology, Faculty of Medicine, Pharmaceutical Health Sciences, Kanazawa University, Kanazawa, Japan.
PMID:
33745200
PMCID:
PMC8250299
DOI:
10.1111/1346-8138.15864
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Chilblains*
Humans
Interferons
SARS-CoV-2
Toes
Substances
Interferons